BOSTON SCIENTIFIC CORP (BSX:NYSE)
$64.38 -0.23 (-0.356%)
Analysed BOSTON SCIENTIFIC CORP (BSX:NYSE) News Sources
Analysts Bullish on Boston Scientific (BSX) Amid Expectations for 30% YoY Growth in 2026
16-04-2026
yahoo.com
Envoy Medical Appoints Chas McKhann to Board of Directors
16-04-2026
yahoo.com
Revisiting Stock Picks Burlington Stores, Boston Scientific, Pinterest
16-04-2026
yahoo.com
A Look At Boston Scientific (BSX) Valuation After The Penumbra Acquisition And Recent Shareholder Returns
15-04-2026
yahoo.com
Boston Scientific (BSX) Outperforms Broader Market: What You Need to Know
15-04-2026
yahoo.com
Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy?
15-04-2026
yahoo.com
AIP to acquire Avanos Medical in $1.27B go-private deal
15-04-2026
medtechdive.com
Citi Reiterates Buy rating for Boston Scientific (BSX)
14-04-2026
yahoo.com
EHRA 2026 Studies Reveal Why False Positives Persist in AI-Equipped Implantable Cardiac Monitors
14-04-2026
yahoo.com
Will Boston Scientific (BSX) Beat Estimates Again in Its Next Earnings Report?
13-04-2026
yahoo.com
What is the current price of BOSTON SCIENTIFIC CORP (BSX:NYSE)?
The current price of BOSTON SCIENTIFIC CORP (BSX:NYSE) is $64.38.
BOSTON SCIENTIFIC CORP (BSX:NYSE) absolute price change since previous trading day?
The absolute price change of BOSTON SCIENTIFIC CORP (BSX:NYSE) since the previous trading day is $-0.23.
BOSTON SCIENTIFIC CORP (BSX:NYSE) percentage price change since previous trading day?
The percentage price change of BOSTON SCIENTIFIC CORP (BSX:NYSE) since the previous trading day is -0.356%.
What is the most recent average sentiment score for BOSTON SCIENTIFIC CORP (BSX:NYSE)?
The most recent average sentiment score for BOSTON SCIENTIFIC CORP (BSX:NYSE) is 76 out of 100.
What is the most recent average sentiment for BOSTON SCIENTIFIC CORP (BSX:NYSE)?
The most recent sentiment for BOSTON SCIENTIFIC CORP (BSX:NYSE) is .
SEC-8K** Filing Available For BOSTON SCIENTIFIC CORP (BSX:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.